Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients

Study of Circulating MicroRNA-125b Levels in Serum Exosomes in Advanced Melanoma

(2014) Estibaliz Alegre et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study

(2013) Eyal Greenberg et al.   BIOMARKERS

Circulating microRNAs predict biochemical recurrence in prostate cancer patients

(2013) L A Selth et al.   BRITISH JOURNAL OF CANCER

Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays

(2013) Jiayu Feng et al.   Genetic Testing and Molecular Biomarkers

Sensitive detection of melanoma metastasis using circulating microRNA expression profiles

(2013) Rie Shiiyama et al.   MELANOMA RESEARCH

Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation

(2013) Paola de Candia et al.   PLoS One

Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status

(2013) Gianpiero Di Leva et al.   PLoS Genetics

SERPINE1 expression discriminates site-specific metastasis in human melanoma

(2012) R. Matthew Klein et al.   EXPERIMENTAL DERMATOLOGY

Serum microRNAs as biomarkers for recurrence in melanoma

(2012) Erica B Friedman et al.   Journal of Translational Medicine

Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

(2012) A Rio-Machin et al.   LEUKEMIA

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

(2011) Avital Gaziel-Sovran et al.   CANCER CELL

The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker

(2011) Hisashi Kanemaru et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

(2011) Lena M. Wulfken et al.   PLoS One

Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins

(2011) V. Liberal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

(2010) M. F. Segura et al.   CLINICAL CANCER RESEARCH

Biomarkers in melanoma

(2009) H. Gogas et al.   ANNALS OF ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Costs of the detection of metastases and follow-up examinations in cutaneous melanoma

(2009) Ulrike Leiter et al.   MELANOMA RESEARCH

The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients

(2008) Rachael L. Morton et al.   ANNALS OF SURGICAL ONCOLOGY